Vascular Solutions' extraction catheters are simple aspiration catheters that make use of a vacuum syringe to withdraw blood clots (thrombus) from various arteries, including those of the coronary and peripheral vasculature.

Intravascular Ultrasound (IVUS) is a catheter-based system that allows physicians to acquire images of diseased vessels from inside the artery.

IVUS aims to provide detailed and accurate measurements of lumen and vessel size, plaque area and volume, and the location of key anatomical landmarks. Volcano's proprietary VH IVUS technology helps differentiate the four plaque types: fibrous, fibro-fatty, necrotic core and dense calcium.

Atrium Medical Corp.’s ClearWay RX is a therapeutic perfusion catheter indicated for localized delivery of therapeutic agents to the coronary and peripheral vasculature.

Medtronic Inc. recently announced the initiation of the first investigational sites in the U.S. to participate in PROTECT, the company’s global study comparing the Endeavor and Cypher drug-eluting stents on key safety metrics, including stent thrombosis – a rare but serious adverse event in which a blood clot forms inside the stent, with the potential to cause heart attack or death.

Medtronic Inc. will showcase its Export Aspiration Catheter at TCT 2008. Recent results from an independent study, called TAPAS, showed that thrombus aspiration with the Export Aspiration Catheter prior to stenting can improve blood flow and survival rates in patients suffering acute myocardial infarction (AMI) compared to treatment with percutaneous coronary intervention (PCI) alone.

Medtronic Inc. will feature its FDA-cleared Talent Abdominal Stent Graft on the CoilTrac Delivery System for the treatment of abdominal aortic aneurysms.

August 25, 2008 - Vermillion Inc. said last week a study published in the August 2008 issue of the journal Vascular Medicine included data supporting its peripheral artery disease (PAD) diagnostic program.

The study was led by John Cooke, M.D., Ph.D., professor of medicine at Stanford University and involved researchers at Stanford, Mt. Sinai Medical Center (New York) and Vermillion.

August 25, 2008 - A study conducted by the Cardiovascular Research Institute, Washington Hospital Center, Washington, D.C. indicates both drug-eluting stents (DES) and bare metal stents (BMS) for catheter-based treatment of saphenous vein graft (SVG) stenoses provide acceptably safe and efficacious results, but unlike the case in native coronary arteries, DES use does not reduce the frequency of the need for repeat revascularization.

The study is published in the Sept. 1 issue of the American Journal of Cardiology.

August 25, 2008 - Starion Instruments said a study recently presented at the 2008 Annual Scientific Meeting of the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) found Starion’s Tissue Ligating Shears provides a safe and effective solution for endoscopic harvesting of the radial artery and saphenous vein.

August 25, 2008 – Results published in the August issue of the peer-reviewed journal Vascular Medicine, support Vermillion Inc.’s peripheral artery disease (PAD) diagnostic program, the molecular diagnostics company said.
The study was led by John Cooke, M.D., Ph.D., professor of medicine at Stanford University and involved researchers at Stanford, Mt. Sinai Medical Center (New York) and Vermillion.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now